Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Pharmacist delivered smoking cessation program

Registration Number: NCT02123329

Lead Sponsor: Qatar University

Brief Summary: Thirty seven percent of adult male population smoke cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is a key to reducing smoking related diseases and deaths. Health care providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible health care providers and are uniquely situated to initiate behavior change among patients. Many western studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar. A prospective, randomized, controlled trial will be conducted at 8 ambulatory pharmacies in Qatar. Participants will be randomly assigned to receive a 4-session face-to-face structured patient-specific smoking cessation program conducted by the pharmacist or 5 to 10 minutes of unstructured brief smoking cessation advice given by the pharmacist. Both groups will be offered nicotine therapy if feasible. The primary outcome of smoking cessation will be confirmed by exhaled carbon monoxide test at 12 months. If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease smoking burden.

Detailed Description: Not available

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 314

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention arm	Pharmacist delivered smoking cessation program	Participants assigned to the intervention arm will participate in a face-to-face 4-session program at the pharmacy delivered by the study pharmacist at 2-4-week intervals over 8 weeks in addition to nicotine replacement therapy. The sessions will be set at a date and time that is convenient for both the pharmacist and the participant. The pharmacist will deliver the program at a time different from his or her pharmacy duty regular time.

Primary Outcome Measures

Name	Time	Method
Self-reported 30 Day Smoking Abstinence	3 months	Self-reported 30-day point prevalence abstinence defined as having smoked no cigarettes in the last 30 days
Self-reported Continuous Abstinence at 3 Months	3 months	Self-reported continuous abstinence defined as having smoked no cigarettes since quit day
Objective Smoking Abstinence	12 months	Smoking abstinence as objectively verified by the CO exhaled test at 12 months
Self-reported 7-day Point Prevalence Abstinence	12 months	Defined as having smoked no cigarettes for the previous 7 days
Self-reported 30-day Point Prevalence Abstinence	12 months	Defined as having smoked no cigarettes in the last 30 days
Self-reported Continuous Abstinence	12 months	Defined as having smoked no cigarettes since quit day at 12 months